263 related articles for article (PubMed ID: 34843112)
21. Donor-derived cell-free DNA is associated with cardiac allograft vasculopathy.
Holzhauser L; Clerkin KJ; Fujino T; Alenghat FJ; Raikhelkar J; Kim G; Sayer G; Uriel N
Clin Transplant; 2021 Mar; 35(3):e14206. PubMed ID: 33368611
[TBL] [Abstract][Full Text] [Related]
22. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
Transpl Int; 2023; 36():11899. PubMed ID: 38020751
[TBL] [Abstract][Full Text] [Related]
23. The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring.
Mehlman Y; Valledor AF; Moeller C; Rubinstein G; Lotan D; Rahman S; Oh KT; Bae D; DeFilippis EM; Lin EF; Lee SH; Raikhelkar JK; Fried J; Theodoropoulos K; Colombo PC; Yuzefpolskaya M; Latif F; Clerkin KJ; Sayer GT; Uriel N
Clin Transplant; 2023 Dec; 37(12):e15131. PubMed ID: 37897211
[TBL] [Abstract][Full Text] [Related]
24. Donor-derived cell-free DNA and renal allograft rejection in surveillance biopsies and indication biopsies.
Chang JH; Alvarado Verduzco H; Toma K; Sritharan S; Mohan S; Husain SA
Clin Transplant; 2022 Apr; 36(4):e14561. PubMed ID: 34913202
[TBL] [Abstract][Full Text] [Related]
25. Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding Factors.
Knüttgen F; Beck J; Dittrich M; Oellerich M; Zittermann A; Schulz U; Fuchs U; Knabbe C; Schütz E; Gummert J; Birschmann I
Transplantation; 2022 Mar; 106(3):615-622. PubMed ID: 33653997
[TBL] [Abstract][Full Text] [Related]
26. Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients - A Proof-of-Concept Study.
Kamath M; Shekhtman G; Grogan T; Hickey MJ; Silacheva I; Shah KS; Shah KS; Hairapetian A; Gonzalez D; Godoy G; Reed EF; Elashoff D; Bondar G; Deng MC
Front Immunol; 2022; 13():825108. PubMed ID: 35251005
[TBL] [Abstract][Full Text] [Related]
27. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial.
Kobashigawa J; Patel J; Azarbal B; Kittleson M; Chang D; Czer L; Daun T; Luu M; Trento A; Cheng R; Esmailian F
Circ Heart Fail; 2015 May; 8(3):557-64. PubMed ID: 25697852
[TBL] [Abstract][Full Text] [Related]
28. Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients.
Ju C; Xu X; Zhang J; Chen A; Lian Q; Liu F; Liu H; Cai Y; Zou Y; Yang Y; Zhou Y; He J
BMC Pulm Med; 2023 Jan; 23(1):37. PubMed ID: 36703125
[TBL] [Abstract][Full Text] [Related]
29. Early elevated donor-derived cell-free DNA levels in heart transplant recipients following precision-controlled cardiac transport system or ice-cooled organ transport.
Alam A; van Zyl JS; Afzal A; Felius J; Hall SA; Meyer DM; Carey SA
Clin Transplant; 2023 Dec; 37(12):e15151. PubMed ID: 37922318
[TBL] [Abstract][Full Text] [Related]
30. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
[TBL] [Abstract][Full Text] [Related]
31. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators.
Shah P; Agbor-Enoh S; Lee S; Andargie TE; Sinha SS; Kong H; Henry L; Park W; McNair E; Tchoukina I; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Marboe C; Berry GJ; Valantine HA;
Circ Heart Fail; 2024 Apr; 17(4):e011160. PubMed ID: 38375637
[TBL] [Abstract][Full Text] [Related]
32. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
[TBL] [Abstract][Full Text] [Related]
33. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.
Levitsky J; Kandpal M; Guo K; Kleiboeker S; Sinha R; Abecassis M
Am J Transplant; 2022 Feb; 22(2):532-540. PubMed ID: 34510731
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management.
Qazi Y; Patel A; Fajardo M; McCormick S; Fehringer G; Ahmed E; Malhotra M; Demko ZP; Billings PR; Tabriziani H; Gauthier P
Transplant Proc; 2021 Dec; 53(10):2866-2872. PubMed ID: 34774309
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
Bu L; Gupta G; Pai A; Anand S; Stites E; Moinuddin I; Bowers V; Jain P; Axelrod DA; Weir MR; Wolf-Doty TK; Zeng J; Tian W; Qu K; Woodward R; Dholakia S; De Golovine A; Bromberg JS; Murad H; Alhamad T
Kidney Int; 2022 Apr; 101(4):793-803. PubMed ID: 34953773
[TBL] [Abstract][Full Text] [Related]
36. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
[TBL] [Abstract][Full Text] [Related]
37. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: A single-center experience.
Nissaisorakarn P; Patel H; Amtul A; Pavlakis M
Clin Nephrol; 2022 Aug; 98(2):65-74. PubMed ID: 35445660
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation.
Mantios E; Filiopoulos V; Constantoulakis P; Liapis G; Vittoraki A; Casas S; Marinaki S; Boletis JN
Transpl Int; 2023; 36():11507. PubMed ID: 37901296
[TBL] [Abstract][Full Text] [Related]
39. Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients.
Keller MB; Meda R; Fu S; Yu K; Jang MK; Charya A; Berry GJ; Marboe CC; Kong H; Luikart H; Ponor IL; Shah PD; Khush KK; Nathan SD; Agbor-Enoh S
Am J Transplant; 2022 Oct; 22(10):2451-2457. PubMed ID: 35322546
[TBL] [Abstract][Full Text] [Related]
40. The impact of active cytomegalovirus infection on donor-derived cell-free DNA testing in heart transplant recipients.
Alam AH; Van Zyl J; Shakoor HI; Farsakh D; Abdelrehim AB; Maliakkal N; Jamil AK; Patel R; Felius J; McKean S; Hall SA
Clin Transplant; 2024 Mar; 38(3):e15287. PubMed ID: 38477177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
